Aimmune teams with Regeneron, Sanofi on peanut allergy drug
October 16, 2017 at 09:19 AM EDT
Oct 16 (Reuters) - Aimmune Therapeutics Inc said on Monday it would collaborate with Regeneron Pharmaceuticals Inc and Sanofi to develop its experimental peanut allergy drug.
